Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-05 | Cevian Capital ABUnternehmen | 9,58M | 143,66M | Kauf | 14,61 - 15,58 | 101,05M | 10,48% |
| 2026-05-27 | Ms. Alison ParkesCCO & Compliance APAC | 153,59 | 2,35k | Acquisition Under Employee Benefit Plan | 15,28 | 1,41k | 12,22% |
| 2026-05-27 | Mr. Paul ConnollyPresident of Global Operations | 1,19k | 18,18k | Acquisition Under Employee Benefit Plan | 15,28 | 38,00k | 3,23% |
| 2026-05-27 | Dr. Deepak S. NathCEO & Director | 6,26k | 95,65k | Acquisition Under Employee Benefit Plan | 15,28 | 414,72k | 1,53% |
| 2026-05-27 | Mr. Scott SchaffnerPresident of Sports Medicine | 2,15k | 32,83k | Acquisition Under Employee Benefit Plan | 15,28 | 73,41k | 3,01% |
| 2026-05-27 | Mr. John Terence RogersCFO & Executive Director | 61,90 | 945,87 | Acquisition Under Employee Benefit Plan | 15,28 | 77,22k | 0,08% |
| 2026-03-17 | Cevian Capital ABUnternehmen | 9,77M | 158,64M | Kauf | 15,44 - 17,06 | 91,46M | 11,97% |
| 2026-04-15 | Dr. Deepak S. NathCEO & Director | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Mr. Craig GaffinPresident of Global Orthopaedics | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Mr. Mizanu KebedeChief Quality & Regulatory Affairs Officer | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Mr. Paul ConnollyPresident of Global Operations | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Mr. John Terence RogersCFO & Executive Director | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Mr. Scott SchaffnerPresident of Sports Medicine | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Dr. Rohit KashyapPresident of Advanced Wound Management & Global Commercial Operations | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Dr. Vasant PadmanabhanPresident Research & Development, ENT and Emerging Markets | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Ms. Elga LohlerChief HR Officer | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Ms. Helen BarracloughGroup General Counsel & Company Secretary | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Ms. Alison ParkesCCO & Compliance APAC | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Dr. Ajay DhankharChief Corporate Development & Strategy Officer | 50,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Mr. John Terence RogersCFO & Executive Director | 266,56k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Dr. Ajay DhankharChief Corporate Development & Strategy Officer | 152,76k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Mr. Craig GaffinPresident of Global Orthopaedics | 115,49k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Ms. Elga LohlerChief HR Officer | 102,51k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Mr. Paul ConnollyPresident of Global Operations | 77,97k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Dr. Rohit KashyapPresident of Advanced Wound Management & Global Commercial Operations | 167,34k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Dr. Vasant PadmanabhanPresident Research & Development, ENT and Emerging Markets | 99,09k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Mr. Mizanu KebedeChief Quality & Regulatory Affairs Officer | 75,21k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Ms. Alison ParkesCCO & Compliance APAC | 27,06k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Mr. Scott SchaffnerPresident of Sports Medicine | 172,02k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Dr. Deepak S. NathCEO & Director | 487,91k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Ms. Helen BarracloughGroup General Counsel & Company Secretary | 77,48k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-01-20 | Cevian Capital ABUnternehmen | 4,92M | 80,44M | Kauf | 15,84 - 16,53 | 81,69M | 6,41% |
| 2026-01-16 | Mr. Paul ConnollyPresident of Global Operations | 410,11 | 10,62k | Acquisition Under Employee Benefit Plan | 25,90 | 473,00 | 652,05% |
| 2026-01-16 | Mr. Craig GaffinPresident of Global Orthopaedics | 206,80 | 5,36k | Acquisition Under Employee Benefit Plan | 25,90 | 305,00 | 210,58% |
| 2026-01-16 | Dr. Deepak S. NathCEO & Director | 410,11 | 10,62k | Acquisition Under Employee Benefit Plan | 25,90 | 5,08k | 8,77% |
| 2026-01-16 | Mr. Scott SchaffnerPresident of Sports Medicine | 242,59 | 6,28k | Acquisition Under Employee Benefit Plan | 25,90 | 1,67k | 17,02% |
| 2025-11-11 | Mr. Scott SchaffnerPresident of Sports Medicine | 29,15 | 970,62 | Acquisition Under Employee Benefit Plan | 33,29 | 1,55k | 1,92% |
| 2025-11-11 | Dr. Deepak S. NathCEO & Director | 24,81 | 825,95 | Acquisition Under Employee Benefit Plan | 33,29 | 4,88k | 0,51% |
| 2025-11-11 | Mr. Craig GaffinPresident of Global Orthopaedics | 22,51 | 749,40 | Acquisition Under Employee Benefit Plan | 33,29 | 202,00 | 12,54% |
| 2025-11-11 | Mr. Mizanu KebedeChief Quality & Regulatory Affairs Officer | 12,03 | 400,62 | Acquisition Under Employee Benefit Plan | 33,29 | 431,00 | 2,87% |
| 2025-11-11 | Mr. Paul ConnollyPresident of Global Operations | 24,72 | 822,98 | Acquisition Under Employee Benefit Plan | 33,29 | 268,00 | 10,16% |
| 2025-11-11 | Dr. Deepak S. NathCEO & Director | 1,78k | 0,00 | Derivative Exercise and Retained Stock | - | 296,13k | 0,60% |
| 2025-11-11 | Dr. Deepak S. NathCEO & Director | -1,24k | 20,53k | Derivative Exercise and Sale | 16,56 | 296,13k | - |
| 2025-11-07 | Mr. Scott SchaffnerPresident of Sports Medicine | 746,79 | 12,20k | Acquisition Under Employee Benefit Plan | 16,33 | 71,26k | 1,06% |
| 2025-11-07 | Dr. Deepak S. NathCEO & Director | 2,62k | 42,86k | Acquisition Under Employee Benefit Plan | 16,33 | 294,35k | 0,90% |
| 2025-11-07 | Mr. Mizanu KebedeChief Quality & Regulatory Affairs Officer | 4,17 | 68,15 | Acquisition Under Employee Benefit Plan | 16,33 | 10,81k | 0,04% |
| 2025-11-07 | Mr. Paul ConnollyPresident of Global Operations | 394,42 | 6,44k | Acquisition Under Employee Benefit Plan | 16,33 | 36,81k | 1,08% |
| 2025-09-09 | Dr. Vasant PadmanabhanPresident Research & Development, ENT and Emerging Markets | -17,64k | 340,22k | Verkauf | 19,28 | 135,56k | -11,52% |
| 2025-08-27 | Dr. Ajay DhankharChief Corporate Development & Strategy Officer | 249,31k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-08-22 | Mr. Simon Jonathan LowthIndependent Non-Executive Director | 355,00 | 6,65k | Kauf | 18,73 | 655,00 | 118,33% |
| 2025-08-22 | Ms. Angela Susan RisleyInsider | 373,00 | 6,98k | Kauf | 18,71 | 6,35k | 6,24% |
| 2025-08-22 | Mr. Jeremy Kim MaidenIndependent Non-Executive Director | 353,00 | 6,59k | Kauf | 18,66 | 3,50k | 11,21% |
| 2025-08-22 | Dr. Katarzyna Mazur-HofsaessIndependent Non-Executive Director | 541,00 | 10,14k | Kauf | 18,74 | 2,37k | 29,56% |
| 2025-08-22 | Ms. Joanna Christine HallasIndependent Non-Executive Director | 389,00 | 7,29k | Kauf | 18,73 | 6,58k | 6,28% |
| 2025-08-22 | Mr. Marc Ellis OwenIndependent Non-Executive Director | 202,00 | 7,52k | Kauf | 37,25 | 0,00 | -100,00% |
| 2025-08-22 | Dr. Changzheng MaIndependent Non-Executive Director | 305,00 | 11,36k | Kauf | 37,25 | 0,00 | -100,00% |
| 2025-08-20 | Ms. Sybella Jane StanleyIndependent Non-Executive Director | 1,52k | 28,48k | Kauf | 18,73 | 5,33k | 39,90% |
| 2025-08-18 | Dr. Deepak S. NathCEO & Director | 25,83k | 0,00 | Derivative Exercise and Retained Stock | - | 291,73k | 9,72% |
| 2025-08-18 | Dr. Deepak S. NathCEO & Director | -18,01k | 328,90k | Derivative Exercise and Sale | 18,27 | 291,73k | - |
| 2025-08-06 | Ms. Elga LohlerChief HR Officer | -12,56k | 224,69k | Verkauf | 17,89 | 177,82k | -6,60% |
| 2025-07-09 | Mr. Scott SchaffnerPresident of Sports Medicine | 298,19 | 8,88k | Acquisition Under Employee Benefit Plan | 29,77 | 1,53k | 24,21% |
| 2025-07-09 | Dr. Deepak S. NathCEO & Director | 512,30 | 15,25k | Acquisition Under Employee Benefit Plan | 29,77 | 4,87k | 11,76% |
| 2025-07-09 | Mr. Craig GaffinPresident of Global Orthopaedics | 381,29 | 11,35k | Acquisition Under Employee Benefit Plan | 29,77 | 191,00 | -200,37% |
| 2025-07-09 | Mr. Mizanu KebedeChief Quality & Regulatory Affairs Officer | 114,62 | 3,41k | Acquisition Under Employee Benefit Plan | 29,77 | 425,00 | 36,93% |
| 2025-07-09 | Mr. Paul ConnollyPresident of Global Operations | 512,30 | 15,25k | Acquisition Under Employee Benefit Plan | 29,77 | 256,00 | -199,88% |
| 2025-05-14 | Cevian Capital ABUnternehmen | 7,99M | 115,98M | Kauf | 14,07 - 15,17 | 74,47M | 12,02% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
